UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013647
Receipt number R000015929
Scientific Title the Setouchi Breast Cancer Cohort Study
Date of disclosure of the study information 2014/04/07
Last modified on 2018/04/09 07:51:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

the Setouchi Breast Cancer Cohort Study

Acronym

SBCCS

Scientific Title

the Setouchi Breast Cancer Cohort Study

Scientific Title:Acronym

SBCCS

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

The primary purpose of the Setouchi Breast Cancer Cohort Study (SBCCS) is to investigate the effect on breast cancer outcomes of modifiable lifestyle factors after breast cancer diagnosis. A further purpose is to evaluate the status of breast cancer survivors, including physical, functional, social, and psychological well-being, and the needs of survivors after diagnosis, based on a comprehensive and longitudinal investigation.

Basic objectives2

Others

Basic objectives -Others

The primary purpose of the Setouchi Breast Cancer Cohort Study (SBCCS) is to investigate the effect on breast cancer outcomes of modifiable lifestyle factors, including physical activity, smoking, alcohol consumption, obesity and weight gain after diagnosis, alternative medicine, and dietary factors, after breast cancer diagnosis. A further purpose is to evaluate the status of breast cancer survivors, including physical, functional, social, and psychological well-being, and the needs of survivors after diagnosis, based on a comprehensive and longitudinal investigation.

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

disease-free survival (DFS), defined as the time from enrollment to the earliest documentation of disease relapse, asynchronous breast cancer, any secondary cancer, or death due to any cause.

Key secondary outcomes

Secondary endpoints include overall survival (OS), health-related quality of life (HRQoL), breast cancer-related symptoms, and adverse events.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

(i)Histological or cytological diagnosis of breast cancer and planned radical treatment for the disease at a participating institution.
(ii)Women aged 20 years old or above.
(iii)Signed written informed consent.

Key exclusion criteria

Exclusion Criteria
(i)Breast cancer with distant metastasis (Stage IV).
(ii)Ineligibility for the study based on the decision of an investigator.

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naruto Taira

Organization

Okayama university hoispital

Division name

Department of Breast and endocrine surgery

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan

TEL

+81-86-235-7265

Email

ntaira@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Doumae, Fujiwara

Organization

the Non-Profit Organization Setouchi Breast Project Comprehensive Support (SBP-CS)

Division name

Office

Zip code


Address

2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan

TEL

+81-86-235-7265

Homepage URL

http://setouchi-bp.com/

Email

office@setouchi-bp.com


Sponsor or person

Institute

the Non-Profit Organization Setouchi Breast Project Comprehensive Support (SBP-CS)

Institute

Department

Personal name



Funding Source

Organization

the Non-Profit Organization Setouchi Breast Project Comprehensive Support (SBP-CS

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

National Cancer Center, Research Center for Cancer Prevention and Screening

Name of secondary funder(s)

Health and Labour Sciences Research Grant (Clinical Cancer Research,H22-035, H25-A-16); Grant-in-Aid for Scientific Research (C,24591906) ; Research Support from AstraZeneca K.K. (United States).


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

香川県立中央病院(香川県)
四国がんセンター(愛媛県)
岡山赤十字病院(岡山県)
福山医療センター(広島県)        
水島協同病院(岡山県)      
愛媛県立中央病院(愛媛県)      
高知医療センター(高知県)
岡山労災病院(岡山県)       
福山市民病院(広島県)
岡山医療センター(岡山県)        
広島市立広島市民病院 ( 広島県)        
松江赤十字病院(島根県)           
姫路聖マリア病院(兵庫県)
高知大学病院(高知県)
川崎医科大学附属病院(岡山県)


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2012 Year 08 Month 10 Day

Date of IRB


Anticipated trial start date

2013 Year 02 Month 21 Day

Last follow-up date

2023 Year 02 Month 20 Day

Date of closure to data entry

2024 Year 02 Month 20 Day

Date trial data considered complete

2024 Year 02 Month 20 Day

Date analysis concluded

2024 Year 02 Month 20 Day


Other

Other related information

Lifestyle
Lifestyle at the time of and after breast cancer diagnosis will be assessed using a self-reported questionnaire developed in the Japan Public Health Center-based Prospective Study (JPHC study).

Psychosocial factors
Psychosocial factors will be assessed using the Public Health Research Foundation - Stress Check List (PHRF-SCL), Stress-Coping Assessment Questionnaire, Health Hope Index (HHI), Perceived Positive Change, and Hospital Anxiety and Depression Scale (HADS).

Social background and reproductive factors
Marital status, children, presence of partner, household income, educational background, and work status will be assessed using original items. Menstrual status at the time of and after breast cancer diagnosis, and reproductive and breastfeeding history will also be assessed using original items.

Health related quality of life (HRQoL) and patient-reported symptoms
HRQoL will be assessed using established questionnaires: the Functional Assessment of Cancer Therapy (FACT) -Endocrine Symptoms (ES), -Breast (B), and -Taxane; and the MOS 36-Item Short-Form Health Survey (SF36&reg;). Cancer-related fatigue will be assessed using the Cancer Fatigue Scale (CFS). Chemotherapy-induced peripheral neurotoxicity will be assessed using the Patient Neurotoxicity Questionnaire (PNQ). Breast cancer-related symptoms will be assessed using 25 items on an original self-reported symptoms checklist developed for this study.

Other factors
The status of use of alternative medicine after breast cancer diagnosis and the informational and supportive needs of patients at each time point will be assessed using original items.

Evaluation points
The evaluation time points for each questionnaire are at registration (baseline) and at 1, 2, 3 and 5 years after registration.


Management information

Registered date

2014 Year 04 Month 05 Day

Last modified on

2018 Year 04 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015929


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name